Financials

  • Market Capitalization 427.7 M
  • Employee 23
  • Founded 2014
  • CEO N/A
  • Website www.ovidrx.com
  • Headquarter Delaware, United States
  • FIGI BBG009F0TD76
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.09
市销率
16.57

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2952
ENTX
Entera Bio Ltd. - Ordinary Shares
2.49 USD-6.04%-0.80%-11.39%-2.35%431.12 M USD
2959
PRTA
Prothena Corporation plc - Ordinary Shares
8.36 USD-0.83%+5.42%-6.59%-18.99%429.18 M USD
2976
DMAC
DiaMedica Therapeutics Inc. - Common Stock
7.82 USD-4.63%-2.37%+20.49%+11.08%421.70 M USD
2979
SLN
Silence Therapeutics Plc - American Depository Share
8.87 USD-8.08%-9.21%-31.03%+57.83%419.08 M USD

新闻